Hematologist-Oncologist: Kenneth Micetich, MD | Loyola Medicine

COVID-19 (Coronavirus) Update

Loyola Medicine is resuming select health care services. Learn more about resumption of services.

Kenneth Micetich, MD

Kenneth Micetich, MD


Program Director, Institutional Review Board (IRB)

Languages Spoken

Patient Ratings
4.9 / 5 (53 Ratings)

Clinical Expertise

  • Breast Cancer
  • Gastrointestinal Cancer
  • Gastrointestinal Stromal Tumor (GIST)
  • Lung Cancer

About Dr. Micetich


Medical Education

Medical School
Loyola University Chicago Stritch School of Medicine
Loyola University Medical Center - Internal Medicine: General
  • Loyola University Medical Center - Internal Medicine: Medical Oncology
  • National Cancer Institute (NCI) - Internal Medicine: Medical Oncology

Board Certification

American Board of Internal Medicine
American Board of Internal Medicine Subspecialty Medical Oncology


  • SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma Ben-Josef, E.; Guthrie, K. A.; El-Khoueiry, A. B.; Corless, C. L.; Zalupski, M. M.; Lowy, A. M.; Thomas, C. R., Jr; Alberts, S. R.; Dawson, L. A.; Micetich, K. C.; Thomas, M. B.; Siegel, A. B.; Blanke, C. D., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma El-Khoueiry, A. B.; Rankin, C.; Siegel, A. B.; Iqbal, S.; Gong, I. Y.; Micetich, K. C.; Kayaleh, O. R.; Lenz, H. J.; Blanke, C. D., British journal of cancer
  • The depth of post-treatment perirectal tissue invasion is a predictor of outcome in patients with clinical T3N1M0 rectal cancer treated with neoadjuvant chemoradiation followed by surgical resection Brandt, W. S.; Yong, S.; Abood, G.; Micetich, K.; Walther, A.; Shoup, M., American Journal of Surgery
View All ResearchShow Less
  • Sweet's syndrome with neurologic manifestations in a patient with esophageal adenocarcinoma: case report and review of the literature Sobol, Urszula A.; Sherman, Karen L.; Smith, Jason; Nagda, Suneel N.; Micetich, K. C.; Nickoloff, Brian J.; Shoup, M. C., International journal of dermatology
  • Is artificial nutrition and hydration extraordinary care? Micetich, K. C., The virtual mentor : VM
  • Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors. Paner, G. P.; Silberman, S.; Hartman, G.; Micetich, K. C.; Aranha, G. V.; Alkan, S., Anticancer Research
  • Competing clinical trials in the same institution: ethical issues in subject selection and informed consent Gordon, E. J.; Micetich, K. C., Irb
  • Long-term survival of a patient with widespread metastases from Barrett's adenocarcinoma Mason, G. R.; Micetich, K.; Aranha, G. V., European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology